Fig. 6From: Computer-aided identification of a series of novel ligands showing high potency as hepatitis C virus NS3/4A protease inhibitorsThe 3D and 2D interaction of the designed Molecule (Molecule 7, see Table 6) with better activity to Telaprevir, Simeprevir, and Voxilaprevir (approved direct-acting antiviral agents) with the binding pocket of 3D structures of HCV NS3/4a protease/helicase (PDB ID: 4A92)Back to article page